ストックスクリーナーアプリを入手
9.98
0.10%
-0.010
アフターアワーズ：
9.98
前日終値:
$9.99
開ける：
$9.98
24時間の取引高:
1,618
Relative Volume:
0.02
時価総額：
$234.23M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.10%
1か月 パフォーマンス:
-0.10%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$9.98
$9.98
1週間の範囲:
$9.95
$10.00
52週間の値動き範囲:
$9.94
$10.01
Apogee Acquisition Corp Stock (AACP) Company Profile
名前
Apogee Acquisition Corp
セクター
電話
771.210.4643
住所
2106 HOUSE AVE SUITE 375, CHEYENNE
Compare AACP vs LION, XXI, UMAC, CCXI, DMII
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AACP
Apogee Acquisition Corp
|
9.98 | 234.47M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.29 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.31 | 1.78B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
18.68 | 823.01M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
15.97 | 798.74M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.10 | 642.73M | 0 | 8.58M | -1.11M | 0.134 |
Apogee Acquisition Corp (AACP) 最新ニュース
Apogee Therapeutics (NASDAQ: APGE) backs AbbVie’s $135.11‑per‑share all‑cash deal - Stock Titan
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition (AACP) Stock Trends and Sentiment 2026 - MarketBeat
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Acquisition Corp Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Apogee Acquisition Corp Rings the Closing Bell - Nasdaq
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Iron Dome Acquisition Corporation Rings the Nasdaq Stock Market Opening Bell - Nasdaq
AACPU Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPR - TradingView
AACPR Stock Price, News & Analysis - Stock Titan
APOGEE ACQUISITION (AACPW) Stock Price, News & Analysis - Stock Titan
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACPR - TradingView
AbbVie acquires Apogee Therapeutics for $10.9 billion - qz.com
Apogee Therapeutics (APGE) Proxy filing Summary - Quartr
AbbVie to buy Apogee Therapeutics (APGE) for $135.11 per share — significant premium - Stock Titan
Enterprise value to EBITDA forward of Apogee Acquisition Corp – NASDAQ:AACP - TradingView
Apogee Enterprises Completes $115 Million Acquisition of Kalwall Companies to Expand Architectural Solutions - Minichart
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News - Insider Monkey
Apogee completes strategic acquisition of Keller Companies - TipRanks
Apogee Enterprises completes Kalwall acquisition for $115 million - Investing.com
Apogee Enterprises completes acquisition of Kalwall Companies - scanx.trade
Apogee Enterprises, Inc. acquired Kalwall Corporation from the Keller family. - marketscreener.com
Ares Acquisition Corporation III Announces Pricing of Upsized $345 Million Initial Public Offering - Yahoo Finance
Enterprise value to EBIT forward of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
AbbVie Announces $10.9 Billion Acquisition of Apogee Therapeutics - HarianBasis.co
Enterprise value to revenue forward of Apogee Acquisition Corp – BOATS:AACPU - TradingView
Price to sales forward of Apogee Acquisition Corp – BOATS:AACPU - TradingView
Enterprise value to revenue forward of Apogee Acquisition Corp – NASDAQ:AACPW - TradingView
Deal Dispatch: Penske Buys Vox Media's Digital Brands, AbbVie Acquires Apogee Therapeutics For $10.9 Bill - Benzinga
AACPR|Apogee Acquisition Rights|| - TradingKey
Price to book forward of Apogee Acquisition Corp – NASDAQ:AACPU - TradingView
Price to sales forward of Apogee Acquisition Corp – NASDAQ:AACPU - TradingView
Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition - Investing.com
Mizuho downgrades Apogee Therapeutics stock on AbbVie acquisition By Investing.com - Investing.com Canada
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - Yahoo Finance
AbbVie Acquires Apogee Therapeutics for 10.9 Billion Dollars - HarianBasis.co
Cash buyout for Apogee (NASDAQ: APGE) at $135.11 a share - Stock Titan
AACP|Apogee Acquisition Ord Shs Class A|Price:9.960|Chg%:0.00 - TradingKey
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition - Insider Monkey
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio - Investing News Network
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger - Yahoo Finance
AbbVie: Apogee Acquisition Brings Significant Weight to Immunology Pipeline - Morningstar
AbbVie sharpens immunology focus with $10.9 billion Apogee deal - 102.7 WBOW
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition (NASDAQ:APGE) - Seeking Alpha
AbbVie to Acquire Apogee Therapeutics for $10.9B - Genetic Engineering and Biotechnology News
AbbVie Acquires Apogee Therapeutics in 10.9 Billion Dollar Deal - HarianBasis.co
Apogee Enterprises Acquires Kalwall Companies for 115 Million Dollars - HarianBasis.co
AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs - BioPharma Dive
Apogee Enterprises (APOG) Makes a $115 Million Bet; Could This Acquisition Reshape Its Growth Story? - Insider Monkey
AbbVie Buys Apogee for $10.9 Billion to Acquire Inflammatory Disease Drug Pipeline - streamlinefeed.co.ke
Apogee Acquisition Corp (AACP) 財務データ
Apogee Acquisition Corp (AACP) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.08%
0.47%
大文字化:
|
ボリューム (24 時間):